| Symbol | CAMP |
|---|---|
| Name | CAMP4 THERAPEUTICS CORP |
| Sector | UNDEFINED |
| Region | UNDEFINED |
| Industry | Pharmaceutical Preparations |
| Address | ONE KENDALL SQUARE, CAMBRIDGE, MA 02139 |
| Telephone | 617-651-8867 |
| Fax | — |
| — | |
| Website | — |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | — |
| Description | None |
CAMP4 Therapeutics Preprints Pioneering Study on Regulatory RNA Profiling and Gene Upregulation
Read moreNew Form DEFA14A - Camp4 Therapeutics Corp <b>Filed:</b> 2026-04-23 <b>AccNo:</b> 0001736730-26-000028 <b>Size:</b> 1 MB
Read moreNew Form DEF 14A - Camp4 Therapeutics Corp <b>Filed:</b> 2026-04-23 <b>AccNo:</b> 0001736730-26-000026 <b>Size:</b> 2 MB
Read moreCAMP4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Read moreTardiff Daniel 🟢 acquired 170.0K shares (1 derivative) of Camp4 Therapeutics Corp (CAMP) at $4.46 Transaction Date: Apr 01, 2026 | Filing ID: 000003
Read moreMaricich Yuri 🟢 acquired 215.0K shares (1 derivative) of Camp4 Therapeutics Corp (CAMP) at $4.46 Transaction Date: Apr 01, 2026 | Filing ID: 000002
Read moreGold Kelly 🟢 acquired 215.0K shares (1 derivative) of Camp4 Therapeutics Corp (CAMP) at $4.46 Transaction Date: Apr 01, 2026 | Filing ID: 000002
Read moreDirector Mandel-Brehm Josh 🟢 acquired 580.0K shares (1 derivative) of Camp4 Therapeutics Corp (CAMP) at $4.46 ($2.6M) Transaction Date: Apr 01, 2026 | Filing ID: 000002
Read moreDirector MacLean Michael F 🟢 acquired 56.0K shares (1 derivative) of Camp4 Therapeutics Corp (CAMP) at $4.46 Transaction Date: Apr 01, 2026 | Filing ID: 000006
Read moreNew Form 3 - Camp4 Therapeutics Corp <b>Filed:</b> 2026-04-03 <b>AccNo:</b> 0001383731-26-000004 <b>Size:</b> 10 KB
Read more